文献速递口腔修复与种植牙周病

全身抗生素对种植体周围炎手术治疗有益吗?系统评价与荟萃分析

Do Systemic Antibiotics Offer Benefits to the Surgical Treatment of Peri-Implantitis? A Systematic Review With Meta-Analyses.
PubMed 文献 · J Clin Periodontol · 2025-08-27

该系统评价纳入7项研究(3项随机、4项非随机,共595例患者、1388枚种植体),评估辅助全身抗生素在种植体周围炎手术治疗中的获益。结果显示短期(1-2年)治疗成功率、骨增益、骨水平稳定性提高,探诊出血和溢脓减少,但仅对改性表面种植体有获益,无长期(≥3年)获益。

要点

  • 辅助全身抗生素可提高短期(1-2年)种植体周围炎手术治疗成功率。
  • 获益主要见于改性表面种植体,且无长期(≥3年)获益。
  • 抗生素可能增加腹泻风险,不良事件数据有限。

核心结论

  • 全身抗生素在短期(1-2年)内对种植体周围炎手术治疗有益,尤其对改性表面种植体。
  • 未见长期(≥3年)实质性获益,不良事件数据 scarce,不确定性仍存在。

研究设计与样本

  • 共纳入7项研究(3项随机、4项非随机),包含595例患者和1388枚种植体。

主要发现

  • 短期治疗成功:5项研究,OR=2.33(95%CI 1.29-4.21)。
  • 骨增益:4项研究,MD=0.37 mm(95%CI -0.68至-0.07)。
  • 骨水平稳定性增加:3项研究,OR=2.73(95%CI 1.50-4.99)。
  • 探诊出血减少:6项研究,OR=0.49(95%CI 0.31-0.78);探诊溢脓减少:3项研究,OR=0.33(95%CI 0.18-0.61)。
  • 牙龈退缩增加:3项研究,MD=0.18 mm(95%CI 0-0.36 mm);仅改性表面种植体获益(OR 4.10 vs 0.79)。

关键数值与推荐

  • 改性表面种植体使用抗生素的OR为4.10, Turned表面为0.79。
  • 一项试验发现抗生素可能增加腹泻风险。

临床怎么用

  • 可考虑对改性表面种植体在手术治疗时短期辅助使用全身抗生素,但需权衡腹泻风险。
  • 不应期望长期(≥3年)获益,需向患者说明证据不确定性。

局限性

  • 纳入研究数量少(7项),且包括非随机研究。
  • 不良事件数据 scarce,长期获益证据不足。
  • 证据确定性需进一步分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To assess the potential benefit of using adjunct systemic antibiotics in surgical peri-implantitis treatment. MATERIALS AND METHODS: Six databases were searched (December 2024) for randomised/non-randomised clinical studies. After duplicate study selection, data extraction and risk-of-bias assessment, random-effects meta-analyses of odds ratios (ORs) or mean differences (MDs) and their 95% confidence intervals (CIs) were performed, followed by the analysis of certainty of evidence. RESULTS: Seven studies (three randomised and four non-randomised, comprising 595 patients and 1388 implants) were included. Systemic antibiotics were associated with greater short-term treatment success (n = 5; OR = 2.33; 95% CI: 1.29-4.21), bone gain (n = 4; MD = 0.37 mm; 95% CI: -0.68 to -0.07), increased bone level stability (n = 3; OR = 2.73; 95% CI: 1.50-4.99), reduced bleeding on probing (n = 6; OR = 0.49; 95% CI: 0.31-0.78), reduced suppuration on probing (n = 3; OR = 0.33; 95% CI: 0.18-0.61) and increased gingival recession (n = 3; MD = 0.18 mm; 95% CI: 0-0.36 mm) (p < 0.05). Systemic antibiotics seem to benefit only implants with modified surfaces (ORs: modified 4.10 vs. turned 0.79), and event that, without long-term benefits (≥ 3 years). Finally, one trial found that antibiotics probably increased diarrhoea risk. CONCLUSIONS: Evidence from randomised/non-randomised studies seems to indicate that systemic antibiotics benefit surgical peri-implantitis treatment, in the short term (1-2 years), especially for implants with a modified surface, while data on adverse effects is scarce. No substantial long-term benefits are seen (≥ 3 years). Uncertainty still exists regarding the potential benefit of systemic antibiotics as adjunct to surgical management of peri-implantitis.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Antonoglou GN, Papageorgiou SN, Carrillo de Albornoz A, et al. Do Systemic Antibiotics Offer Benefits to the Surgical Treatment of Peri-Implantitis? A Systematic Review With Meta-Analyses. J Clin Periodontol. 2025. PMID: 40873154. doi:10.1111/jcpe.70021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。